These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7088380)

  • 1. [Platelet aggregation in hyperlipoproteinemias].
    Calabrese S; Da Col PG; Giansante C; Morgante O; Cattin L
    Minerva Med; 1982 May; 73(22):1541-6. PubMed ID: 7088380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet function in hyperlipoproteinaemia.
    Parízek M; Parízková M; Kubisz P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):752-9. PubMed ID: 2416652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet aggregation and various coagulation parameters in liver cirrhosis].
    Calabrese S; Giansante C; Sammartini C; Benedetti A
    Minerva Med; 1984 Apr; 75(18):1047-52. PubMed ID: 6728255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet factor 3 and 4 in juvenile diabetes and in children of diabetic mothers].
    Calabrese S; Giansante C; Burigana F; Feruglio FS
    Minerva Med; 1981 Sep; 72(34):2255-60. PubMed ID: 7290451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo platelet activity and lipoprotein patterns in coronary artery disease.
    Goubran F; Maklady F; Saad M; el-Ashry M
    Wien Klin Wochenschr; 1986 Apr; 98(7):209-11. PubMed ID: 3705598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activity in vivo in hyperlipoproteinemia--importance of combined hyperlipidemia.
    Bröijersén A; Hamsten A; Eriksson M; Angelin B; Hjemdahl P
    Thromb Haemost; 1998 Feb; 79(2):268-75. PubMed ID: 9493574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of platelet function and coagulation in deafness and sudden vestibular disorders].
    Calabrese S; Giansante C; Oselladore F; Benedetti A; Mitri E
    Minerva Med; 1983 May; 74(22-23):1357-63. PubMed ID: 6602306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of halofenate on triglyceride and uric acid levels, coagulation and platelet behaviour in patients with hyperlipoproteinemia type IV and hyperuricemia (author's transl)].
    Kuntzen O; Hehl FJ; Walter E; Zimmermann R
    Arzneimittelforschung; 1978; 28(12):2349-52. PubMed ID: 227420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pentoxifylline on platelet aggregation.
    Nenci GG; Gresele P; Agnelli G; Ballatori E
    Pharmatherapeutica; 1981; 2(8):532-8. PubMed ID: 7255510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta 2 glycoprotein I analysis in patients with hyperlipoproteinemia, arteriosclerotic occlusive disease and diabetes mellitus].
    Müller G; Biering A; Lux E; Richter V
    Z Gesamte Inn Med; 1983 May; 38(10):282-4. PubMed ID: 6613192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of hyperlipoproteinemia on blood fibrinolytic activity and thrombocyte aggregation].
    Kostić N; Secen S
    Med Pregl; 2000; 53(3-4):180-3. PubMed ID: 10965685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet aggregation in whole blood and prostacyclin in hyperlipemia types II and IV].
    Craveri A; Lanfredini M; Citella C; Barbesti S; Tempesta A; Gallo E
    Minerva Med; 1988 May; 79(5):349-54. PubMed ID: 3374826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperlipoproteinemias in diabetes mellitus].
    Slavina LS; Romanovskaia GA; Kantordzhan IG; Mazovetskiĭ AG; Riazanovskaia IV
    Probl Endokrinol (Mosk); 1983; 29(3):17-21. PubMed ID: 6866949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Spontaneous" platelet aggregation in whole blood in diabetic and non diabetic survivors of acute myocardial infarction.
    Gray RP; Hendra TJ; Patterson DL; Yudkin JS
    Thromb Haemost; 1993 Dec; 70(6):932-6. PubMed ID: 8165614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet alpha 2-adrenergic receptors in hypercholesterolemia: relationship between binding studies and epinephrine-induced platelet aggregation.
    Baldassarre D; Mores N; Colli S; Pazzucconi F; Sirtori CR; Tremoli E
    Clin Pharmacol Ther; 1997 Jun; 61(6):684-91. PubMed ID: 9209252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behaviour of uricemia in hyperlipoproteinemic subjects.
    Zdrenghea D; Marta D; Constantinescu M; Cucuianu M
    Med Interne; 1980; 18(4):385-90. PubMed ID: 7455583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators.
    Aubó C; Sentí M; Marrugat J; Tomás M; Vila J; Sala J; Masiá R
    Eur Heart J; 2000 Jan; 21(1):33-8. PubMed ID: 10610741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
    Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R
    Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
    Wlazłowski R; Kruszyński G; Goch JH
    Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma fibrinogen and platelet-aggregates in type II hyperlipoproteinaemia.
    Lowe GD; Drummond MM; Third JL; Bremner WF; Forbes CD; Prentice CR; Lawrie TD
    Thromb Haemost; 1980 Feb; 42(5):1503-7. PubMed ID: 7368154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.